蝶眶脑膜瘤:独特颅底肿瘤的手术技术与结果
该研究回顾性分析单术者2000至2017年手术的47例蝶眶脑膜瘤患者,采用额颞开颅、眶视神经管截骨和前床突切除并广泛切除受累骨与软组织。
要点
- 额颞开颅联合眶视神经管截骨和前床突切除是核心手术技术。
- 突眼术后改善率高,视力缺损改善与视野缺损类型相关。
- 术后复发或进展率约19%,需长期随访。
核心结论
- 蝶眶脑膜瘤需仔细规划以优化结局,积极切除受累骨和眶骨膜至关重要。
- 突眼和非中心暗点性视野缺损可在术后改善。
研究设计与样本
- 单中心单术者回顾性研究,纳入2000至2017年手术的47例蝶眶脑膜瘤患者。
- 由2名研究成员盲法影像复核确认诊断,并查阅病历获取人口学和结局数据。
主要发现
- 手术时中位年龄47岁(范围36-70岁),女性占81%,中位随访43个月(范围0-175个月)。
- 多变量分析中,非中心暗点性视野缺损是视力改善的唯一预后因素(p=0.0062)。
- 随访期间9例(19%)出现复发或进展。
关键数值与推荐
- 所有手术均采用额颞开颅、眶视神经管截骨和前床突切除,并广泛切除所有受累骨和软组织。
临床怎么用
- 对蝶眶脑膜瘤应采用积极切除受累骨和眶骨膜的策略以改善突眼和视力结局。
- 术前存在非中心暗点性视野缺损的患者视力改善可能性更高,可作为预后参考。
- 术后需长期随访监测复发或进展。
局限性
- 单术者回顾性研究,样本量47例,随访时间范围宽(0-175个月)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Sphenoorbital meningioma (SOM) is a unique skull base tumor, characterized by infiltrative involvement and hyperostosis primarily of the lesser wing of sphenoid bone, with frequent involvement of the orbital compartment. SOM often manifests with proptosis and visual impairment. Surgical technique and outcome are highly variable among studies reported in the literature. The authors present a single-surgeon experience with SOM. METHODS: A retrospective review of a prospectively maintained institutional database was performed. A blinded imaging review by 2 study team members was completed to confirm SOM, after which chart review was carried out to capture demographics and outcomes. All statistical testing was completed using JMP Pro version 14.1.0, with significance defined as p < 0.05. RESULTS: Forty-seven patients who underwent surgery between 2000 and 2017 were included. The median age at surgery was 47 years (range 36-70 years), 81% of patients were female, and the median follow-up was 43 months (range 0-175 months). All operations were performed via a frontotemporal craniotomy, orbitooptic osteotomy, and anterior clinoidectomy, with extensive resection of all involved bone and soft tissue. Preoperatively, proptosis was noted in 44 patients, 98% of whom improved. Twenty-eight patients (60%) had visual deficits before surgery, 21 (75%) of whom improved during follow-up. Visual field defect other than a central scotoma was the only prognostic factor for improvement in vision on multivariate analysis (p = 0.0062). Nine patients (19%) had recurrence or progression during follow-up. CONCLUSIONS: SOM is a unique skull base tumor that needs careful planning to optimize outcome. Aggressive removal of involved bone and periorbita is crucial, and proptosis and visual field defect other than a central scotoma can improve after surgery.
引用
- Kiyofuji S, Casabella AM, Graffeo CS, et al. Sphenoorbital meningioma: a unique skull base tumor. Surgical technique and results. J Neurosurg. 2019. PMID: 31443076. doi:10.3171/2019.6.JNS191158
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。